Clinical trial
The Efficacy and Safety Study for Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis Using Neurovascular Drug-Eluting Balloon Dilatation Catheter: A Prospective Multicentre Single-arm Trial
NCT04949880 is registered in ClinicalTrials.gov with Zhejiang Zylox Medical Device Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety Study for Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis Using Neurovascular Drug-Eluting Balloon Dilatation Catheter: A Prospective Multicentre Single-arm Trial
- Lead sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 2, 2021
- Completion date
- May 31, 2023
- Enrollment
- 132 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial atherosclerosis